Safety and Efficacy of Dihydroartemisinin-Piperaquine in Falciparum Malaria: A Prospective Multi-Centre Individual Patient Data Analysis
Julien Zwang, Elizabeth A. Ashley, Corine Karema et al. · 2009
Read Safety and Efficacy of Dihydroartemisinin-Piperaquine in Falciparum Malaria: A Prospective Multi-Centre Individual Patient Data Analysis by Julien Zwang, Elizabeth A. Ashley, Corine Karema et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006358.txt.
Description
A fixed-dose malaria drug pair, dihydroartemisinin with piperaquine, is a promising drug pair built on artemisinin. Julien Zwang and colleagues pooled individual patient data from seven published studies in a 2009 PLOS ONE analysis. They examined efficacy and tolerability in acute uncomplicated falciparum malaria across multiple centres.
Pooling patient-level data gives a sharper verdict than separate trial summaries. Safety and cure rates can be compared across regions and patient groups. Artemisinin combinations are the backbone of malaria treatment worldwide. Rigorous checks like this guide which combinations health systems should buy. Pooled data of this kind is the best check we have on drugs used by so many.
Catalog record
| CREATOR | Julien Zwang, Elizabeth A. Ashley, Corine Karema et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 65 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006358